Patient-reported outcomes of patients with advanced renal cell carcinoma treated with nivolumab plus ipilimumab versus sunitinib (CheckMate 214): a randomised, phase 3 trial
Published Online: 2019-02-?
Journal: The Lancet Oncology•Publisher: Elsevier BV
Authors: Bernard Escudier•Brian I Rini•Cristina Ivanescu•David Cella•Hans J Hammers•Jean Paty•Justin Doan•Marc-Oliver Grimm•Paul Nathan•Robert J Motzer•Sabeen Mekan•Saby George•Viktor Grünwald
